IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 67 filers reported holding IMMUNE DESIGN CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $137,000 | +3325.0% | 23,468 | +2420.7% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 931 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | -94.6% | 931 | -93.4% | 0.00% | – |
| Q4 2017 | $56,000 | -63.4% | 14,190 | -4.3% | 0.00% | – |
| Q3 2017 | $153,000 | +135.4% | 14,822 | +123.5% | 0.00% | – |
| Q2 2017 | $65,000 | +160.0% | 6,631 | +79.0% | 0.00% | – |
| Q1 2017 | $25,000 | +525.0% | 3,705 | +361.4% | 0.00% | – |
| Q4 2016 | $4,000 | -33.3% | 803 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | -14.3% | 803 | 0.0% | 0.00% | – |
| Q2 2016 | $7,000 | -93.0% | 803 | -90.5% | 0.00% | – |
| Q1 2016 | $100,000 | -41.2% | 8,460 | +0.5% | 0.00% | – |
| Q4 2015 | $170,000 | +66.7% | 8,422 | 0.0% | 0.00% | – |
| Q3 2015 | $102,000 | -39.3% | 8,422 | +3.2% | 0.00% | – |
| Q2 2015 | $168,000 | +73.2% | 8,157 | +77.4% | 0.00% | – |
| Q1 2015 | $97,000 | +12.8% | 4,598 | +63.8% | 0.00% | – |
| Q4 2014 | $86,000 | – | 2,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
| Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
| NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
| Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
| TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
| Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
| Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
| Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |